воскресенье, 5 марта 2017 г.

GlaxoSmithKline plc (GSK) Given "Neutral" Rating at Credit Suisse Group

GlaxoSmithKline plc (GSK) Given "Neutral" Rating at Credit Suisse Group


's stock had its "neutral" rating restated by stock analysts at Credit Suisse Group in a report issued on Thursday. They presently have a GBX 1,750 price target on the stock.



from Biotech News